Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
$790M |
| 2 |
Microsoft
MSFT
|
$769M |
| 3 |
Coca-Cola
KO
|
$720M |
| 4 |
NVIDIA
NVDA
|
$700M |
| 5 |
Amgen
AMGN
|
$697M |
Top Sells
| 1 |
Vanguard Real Estate ETF
VNQ
|
$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$244M |
| 3 |
Oracle
ORCL
|
$214M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
$140M |
Sector Composition
| 1 | Technology | 23.63% |
| 2 | Financials | 12.75% |
| 3 | Consumer Discretionary | 9.87% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTA
3026
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$332M
| $720K | ﹤0.01% |
169,443
-674
| -0.4% | -$2.87K |
|
3027
Emerald Holding
EEX
$1.02B
| $720K | ﹤0.01% |
149,298
+1,097
| +0.7% | +$5.29K |
|
3028
Seres Therapeutics
MCRB
$169M
| $720K | ﹤0.01% |
43,291
+5,855
| +16% | +$97.3K |
|
3029
ASP Isotopes
ASPI
$755M
| $717K | ﹤0.01% |
158,226
+37,948
| +32% | +$172K |
|
3030
ICL Group
ICL
$7.85B
| $717K | ﹤0.01% |
145,072
+66,933
| +86% | +$331K |
|
3031
Jakks Pacific
JAKK
$196M
| $716K | ﹤0.01% |
25,449
+1,258
| +5% | +$35.4K |
|
3032
Angi Inc
ANGI
$811M
| $715K | ﹤0.01% |
43,061
+467
| +1% | +$7.75K |
|
3033
Trevi Therapeutics
TRVI
$854M
| $713K | ﹤0.01% |
173,063
+22,145
| +15% | +$91.2K |
|
3034
Children's Place
PLCE
$121M
| $713K | ﹤0.01% |
68,122
-61,090
| -47% | -$639K |
|
3035
Backblaze
BLZE
$491M
| $712K | ﹤0.01% |
118,349
+193
| +0.2% | +$1.16K |
|
3036
Red River Bancshares
RRBI
$431M
| $704K | ﹤0.01% |
13,043
| – | – |
|
3037
Fresenius Medical Care
FMS
$14.5B
| $704K | ﹤0.01% |
31,074
+8,913
| +40% | +$202K |
|
3038
John Marshall Bancorp
JMSB
$285M
| $696K | ﹤0.01% |
34,646
| – | – |
|
3039
Neurogene
NGNE
$285M
| $693K | ﹤0.01% |
30,317
| – | – |
|
3040
Ocugen
OCGN
$322M
| $692K | ﹤0.01% |
860,244
+93,288
| +12% | +$75.1K |
|
3041
Primis Financial Corp
FRST
$275M
| $692K | ﹤0.01% |
59,342
+18
| +0% | +$210 |
|
3042
Jasper Therapeutics
JSPR
$44.2M
| $691K | ﹤0.01% |
32,337
-70
| -0.2% | -$1.5K |
|
3043
Donegal Group Class A
DGICA
$689M
| $688K | ﹤0.01% |
44,492
+1,773
| +4% | +$27.4K |
|
3044
Acrivon Therapeutics
ACRV
$41.8M
| $685K | ﹤0.01% |
113,840
-2,413
| -2% | -$14.5K |
|
3045
Radiant Logistics
RLGT
$305M
| $683K | ﹤0.01% |
101,895
| – | – |
|
|
TE
3046
T1 Energy Inc.
TE
$309M
| $682K | ﹤0.01% |
264,505
| – | – |
|
3047
Aldeyra Therapeutics
ALDX
$334M
| $682K | ﹤0.01% |
136,733
| – | – |
|
3048
MeiraGTx Holdings
MGTX
$619M
| $682K | ﹤0.01% |
112,021
+12,961
| +13% | +$78.9K |
|
3049
Hudson Technologies
HDSN
$445M
| $681K | ﹤0.01% |
122,056
| – | – |
|
3050
Amplify Energy
AMPY
$155M
| $680K | ﹤0.01% |
113,377
| – | – |
|